Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Events

08 Dec 2026 - 10 Dec 2026
25 Jan 2027 - 28 Jan 2027

AI-Enabled Technology Offers Future Heart Attack Risk Assessment

By HospiMedica International staff writers
Posted on 06 Mar 2024

When doctors diagnose cancer, they typically offer a prognosis and treatment plan based on a staging system that assesses the extent and location of the cancer in the body. More...

Similarly, staging systems exist for common chronic diseases like hypertension, type 1 and type 2 diabetes, and asthma, which depend on various factors that indicate the disease's progression. However, heart disease lacks a clinically relevant staging system for atherosclerosis, a condition that impacts millions worldwide. Now, a new four-stage system has been introduced to measure the progression of coronary artery disease (CAD) by focusing on atherosclerotic plaque which determines future heart attack risk, rather than on secondary symptoms of heart disease.

Historically, the medical approach to heart disease has revolved around surrogates (such as cholesterol), symptoms (like chest pain or breathlessness), or disease consequences (such as ischemia or stenosis). Yet, many coronary lesions causing heart attacks are not linked to these factors, often presenting silently and without causing ischemia or stenosis. Cleerly’s (Denver, CO, USA; www.cleerlyhealth.com) CAD Staging System is an innovative noninvasive imaging-based software tool designed to analyze crucial aspects of coronary atherosclerosis, stenosis, and ischemia. This system aims to provide physicians with a more precise and individualized risk assessment for patients susceptible to major adverse cardiovascular events (MACE), including heart attacks before they occur.

Cleerly’s AI-powered digital care pathway identifies and quantifies atherosclerotic plaque in arteries, revealing not just the quantity but also the type and amount of plaque. The nature of the plaque is a crucial predictor of future heart attack risk and a key indicator of a patient's impending cardiac event. Cleerly transcends traditional heart disease metrics by analyzing, characterizing, and quantifying plaque types, enabling a more accurate assessment of a patient’s heart attack risk. Cleerly’s comprehensive reports offer healthcare professionals a detailed understanding of patient risk, encompassing everything from vessel-specific details and thorough plaque analysis to stenosis scoring. This empowers physicians to convert clinical data into tailored treatment plans for each patient, regardless of the patient’s position in the heart disease spectrum and potentially saving more lives. Cleerly has received Breakthrough Device Designation from the U.S. Food and Drug Administration (FDA) for its CAD Staging System.

“As Cleerly continues to develop cardiovascular innovations to support patients and healthcare professionals, we are honored to have received Breakthrough Device Designation and join the TAP Pilot,” said James K. Min, MD, Founder and CEO of Cleerly. “This designation from the FDA highlights the critical need for better heart disease risk assessment methods. Our approach to heart disease, inspired by the most successful preventive care paradigms in medicine – including mammograms, colonoscopies, and lung CTs – enables personalized diagnosis and risk assessment and exemplifies our commitment to enhancing CAD evaluation, aiming to prevent heart attacks before they occur.”


Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Hand-held Hemoglobin Analyzer
DiaSpect Tm
Syringe Pump
SP50 Series
Resorbable Bovine Collagen Membrane
GenDerm
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image Credit: Shutterstock

Explainable AI Examines Sepsis Mortality Risk and Emergency Care Delays

Preventing sepsis-related deaths in emergency departments (EDs) remains challenging because patient deterioration can result from multiple rapidly evolving and interconnected factors. These include triage... Read more

Patient Care

view channel
Image: A view inside the custom virtual reality environment used in the study: a calm room with a teddy bear, soft colors and large windows looking out over the sea. (Image Credit: Walaa S. Abu Rukbah et al., Virginia Commonwealth University; CC-BY 4.0, https://creativecommons.org/licenses/by/4.0/)

Virtual Reality Program May Reduce Anxiety Before Pediatric Surgery

Presurgery anxiety affects an estimated 50% to 75% of children undergoing surgery and can complicate anesthesia induction, increase postoperative pain, and prolong recovery. Sedation is often used to manage... Read more

Medical Imaging

view channel
Image: A new automated approach could help predict which patients with dystonia will benefit from deep brain stimulation before surgery (Image Credit: Adobe Stock)

AI Uses Routine MRI to Predict Deep Brain Stimulation Response in Dystonia

Dystonia is a debilitating neurological movement disorder characterized by involuntary muscle contractions that cause abnormal movements and postures. Deep brain stimulation (DBS) is one of the few treatments... Read more

Health IT

view channel
Image Credit: Shutterstock

Telemonitoring Program Improves Quality of Life After Heart Failure Discharge

Heart failure is a chronic condition associated with high mortality, frequent hospitalizations, and reduced quality of life. Patients face particularly high risks of readmission and death after discharge,... Read more

Point of Care

view channel
Image: Jessica Ramella-Roman, professor of biomedical engineering at Florida International University, holding the PPRIM (Portable Preterm Imaging) device designed to detect early signs of preterm labor risk. (Photo courtesy of Florida International University)

Handheld Imaging Device May Help Identify Preterm Birth Risk Earlier

Preterm birth, defined as delivery before 37 weeks of pregnancy, can lead to serious neonatal complications, including neurological, developmental, and respiratory problems. However, identifying pregnancies... Read more

Business

view channel
Image: Stryker has acquired ZuriMED, adding the FiberLocker System, a rotator cuff augmentation technology designed to strengthen repairs, to its Sports Medicine portfolio. (Photo courtesy of ZuriMED)

Stryker Completes Acquisition to Broaden Shoulder Surgery Offerings

Stryker (Portage, MI, USA) has completed its acquisition of ZuriMED (Zurich, Switzerland), a privately held developer of the FiberLocker System, expanding its Sports Medicine portfolio with a commercialized... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.